FDA Opioid Review Will Be Led by Team at Ohio State, Califf Says

Subject matter experts at Ohio State University will lead the FDA’s external review into its past opioid decisions, the agency’s head said Monday.

Food and Drug Administration Commissioner Robert M. Califf, in a Twitter post, offered the latest details on the long-awaited review he announced last month along with the agency’s framework for preventing overdose-related deaths nationwide.

Lawmakers have long criticized the FDA’s approval of Purdue’s OxyContin and other addictive drugs without requiring more thorough warning labels and other protections that could help combat misuse.

“I’m optimistic this review will help us move forward in this multi-step process, and ...